Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: A randomized substudy of the ViTATOPS trial
DUSITANOND, P, EIKELBOOM, J. W, BAKER, R, JAMROZIK, K, HANKEY, G. J, THOM, J, GILMORE, G, LOH, K, YI, Q, KLIJN, C. J. M, LANGTON, P, VAN BOCKXMEER, F. M
Published in Stroke (1970) (2005)
Published in Stroke (1970) (2005)
Get full text
Journal Article
Is There Really a Power Shortage in Clinical Trials Testing the “Homocysteine Hypothesis?”
Hankey, G.J, Eikelboom, J.W, Loh, K, Yi, Q, Pizzi, J, Tang, M, Hickling, S, Le, M, Klijn, C.J.M, Dusitanond, P, van Bockxmeer, F, Gelavis, A, Baker, R, Jamrozik, K
Published in Arteriosclerosis, thrombosis, and vascular biology (01.08.2004)
Published in Arteriosclerosis, thrombosis, and vascular biology (01.08.2004)
Get full text
Journal Article
An Outbreak of Botulism in Thailand: Clinical Manifestations and Management of Severe Respiratory Failure
Kongsaengdao, Subsai, Samintarapanya, Kanoksri, Rusmeechan, Siwarit, Wongsa, Adisorn, Pothirat, Chaicharn, Permpikul, Chairat, Pongpakdee, Sunsanee, Puavilai, Wilai, Kateruttanakul, Piraj, Phengtham, Uthai, Panjapornpon, Kanlaya, Janma, Jirayut, Piyavechviratana, Kunchit, Sithinamsuwan, Pasiri, Deesomchok, Athavudh, Tongyoo, Surat, Vilaichone, Warakarn, Boonyapisit, Kanokwan, Mayotarn, Saengduan, Piya-Isragul, Benjamas, Rattanaphon, Aran, Intalapaporn, Poj, Dusitanond, Petcharat, Harnsomburana, Piyathida, Laowittawas, Worapojn, Chairangsaris, Parnsiri, Suwantamee, Jithanorm, Wongmek, Wanna, Ratanarat, Ranistha, Poompichate, Akekarinth, Panyadilok, Hathai, Sutcharitchan, Niwatchai, Chuesuwan, Apinya, Oranrigsupau, Petchdee, Sutthapas, Chumpita, Tanprawate, Surat, Lorsuwansiri, Jakapong, Phattana, Naritchaya
Published in Clinical infectious diseases (15.11.2006)
Published in Clinical infectious diseases (15.11.2006)
Get full text
Journal Article
Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial
Get full text
Journal Article